Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease

Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease

LINKED CONTENT This article is linked to Dominik et al papers. To view these articles, visit https://doi.org/10.1111/apt.17945 and https://doi.org/10.1111/apt.18144

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2024-08, Vol.60 (4), p.540-541
Hauptverfasser: Kountouras, Jannis, Polyzos, Stergios A., Kazakos, Evangelos, Papanikolaou, Ioannis S., Liatsos, Christos, Vardaka, Elisabeth, Tzilves, Dimitrios, Vlachaki, Efthimia
Format: Artikel
Sprache:eng
Schlagworte:
Chronic Disease
Helicobacter Infections - complications
Helicobacter pylori
Humans
Liver Diseases
Metabolic Syndrome
Plasminogen Activator Inhibitor 1 - blood
Plasminogen activator inhibitors
Von Willebrand factor
von Willebrand Factor - metabolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:LINKED CONTENT This article is linked to Dominik et al papers. To view these articles, visit https://doi.org/10.1111/apt.17945 and https://doi.org/10.1111/apt.18144
ISSN:0269-2813
1365-2036
1365-2036
DOI:10.1111/apt.18066